Palisade Bio, Inc. (Nasdaq: PALI) announced that Health Canada has cleared the company's Clinical Trial Application for ASCENTRA-UC, a global ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE